EGFR is a key driver of tumor growth in certain types of cancers, such as lung cancer and glioblastoma, and is also present in neuroendocrine tumors, exhibiting distinct expression patterns in GEP-NETs and lung NETs [15]. Here, EGFR is linked to neuroendocrine neoplasm.